NCT02088398View on ClinicalTrials.gov

Alternative 10 mg/mL Liquid Formulation of ACY 1215 (Ricolinostat) in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Healthy
Interventions
DRUG

ACY-1215

Trial Locations (1)

53704

Covance Clinical Research Unit Incorporated, Madison

Sponsors
All Listed Sponsors
lead

Acetylon Pharmaceuticals Incorporated

INDUSTRY

NCT02088398 - Alternative 10 mg/mL Liquid Formulation of ACY 1215 (Ricolinostat) in Healthy Subjects | Biotech Hunter | Biotech Hunter